Área Sanitaria de Ferrol
Área sanitaria
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (7)
2023
-
Selection of the best of 2022 in clinical cardiology and cardiovascular pharmacotherapy
REC: CardioClinics, Vol. 58, pp. S49-S54
2022
-
Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia
Journal of Clinical Medicine, Vol. 11, Núm. 4
2021
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
2016
-
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530
2012
-
Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: We must be alert
Journal of Neurology, Vol. 259, Núm. 8, pp. 1668-1672